Neogen Chemicals Q2 Results Review - Long Term Growth Remains Intact: IDBI Capital

IDBI Capital Report

Neogen Chemicals Ltd. delivered subdued financial performance in the quarter. Lower lithium and bromine prices, higher financing and depreciation costs led to lower than expected profitability.

Revenue for organic chemicals segment grew by 24% YoY while the revenue for the inorganic chemicals segment declined by 21% YoY owing to lower prices of lithium raw material. Traction in the existing business remains below optimum levels.

However we are sanguine on the company’s progress on the battery chemical front with strong capex plans coupled with a top notch technology partner in the form of MU Ionic Solutions.

Neogen is seeing strong interest for their battery chemicals segment from domestic as well as overseas customers. We maintain our 'Hold' rating on the stock on account of rich valuations with target price of Rs 1,700.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.